These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 14714342)

  • 21. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic therapy following bioprosthetic aortic valve replacement.
    Nowell J; Wilton E; Markus H; Jahangiri M
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):578-85. PubMed ID: 17267235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement.
    Gryaznov AA; Saeyeldin A; Abdelbaky M; Zafar MA; Tanweer M; Papanikolaou D; Imran M; Li Y; Ziganshin BA; Elefteriades JA
    Am J Cardiol; 2020 Aug; 129():71-78. PubMed ID: 32605717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical aortic valve replacement in young women planning on pregnancy: maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol.
    De Santo LS; Romano G; Della Corte A; D'Oria V; Nappi G; Giordano S; Cotrufo M; De Feo M
    J Am Coll Cardiol; 2012 Mar; 59(12):1110-5. PubMed ID: 22421305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
    Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
    Colli A; Verhoye JP; Leguerrier A; Gherli T
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
    Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
    J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
    Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
    Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
    [No Abstract]   [Full Text] [Related]  

  • 29. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
    Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anticoagulation in patients with heart valve replacement in pregnancy].
    Harenberg J
    Z Kardiol; 1998; 87 Suppl 4():63-7. PubMed ID: 9857469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anticoagulant therapy during pregnancy in patients with mechanical valvular prostheses].
    Hanania G; Nassivera L
    Arch Mal Coeur Vaiss; 2001 Oct; 94(10):1073-6. PubMed ID: 11725712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eComment: Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
    Bockeria LA; Skopin II; Kuts EV
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1169. PubMed ID: 19029395
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of different bridging anticoagulation therapies used after mechanical heart valve replacement in Chinese patients - a prospective cohort study.
    Li BX; Liu SD; Qi L; Sun S; Sun W; Li YM; Song B; Wu XA
    J Cardiothorac Surg; 2020 Feb; 15(1):40. PubMed ID: 32093747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair.
    Vaughan P; Waterworth PD
    J Heart Valve Dis; 2005 Sep; 14(5):576-82. PubMed ID: 16245494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard versus low-level anticoagulation combined to low-dose dipyridamole after mitral valve replacement.
    Hassouna A; Allam H; Awad A; Hassaballah F
    Cardiovasc Surg; 2000 Oct; 8(6):491-8. PubMed ID: 10996106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].
    Angelo M; Stockner I; Wiedermann CJ
    Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.